Clinical Trial Update: The Diabetes TeleCare Study [NA]

View source ↗

Summary

This entry notes that the Diabetes TeleCare Study sponsored by the NIDDK has completed, evaluating telecare approaches for Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Diabetes Mellitus, Type 2 | NA | Status: COMPLETED